Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Immunology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (52) clinical trials

A study of the saftey, effectiveness and tolerability of an investigational treatment for individuals with atopic dermatitis. REF: x40-CLN  

Phase

The purpose of this study is to evaluate the efficacy of each strength of INCB018424 cream once daily or twice daily in subjects with atopic dermatitis compared with vehicle cream.

Phase

This research study will evaluate the effectiveness and safety of two concentrations (0.5 percent [%] and 1%) and two application frequencies (once a day and twice a day) of GSK2894512 cream for the topical treatment in adolescent and adult subjects with atopic dermatitis (eczema). Results from this study will be ...

Phase

Do you have moderate to severe Atopic Dermatitis? 

Phase

This research study is being done to evaluate if the investigational drug, GBR 830, is safe and effective in subjects with moderate to severe atopic dermatitis.  This study is also looking at the biological activity of GBR 830 and how it is eliminated from the body.  GBR 830 is an ...

Phase

About the investigational drug The investigational drug is called GBR 830. By targeting cells that cause inflammation, it is hoped that treatment with this investigational drug may help improve symptoms and reduce reliance on topical medications.   Who will be joining the study? Approximately 392 people with eczema will enroll ...

Phase

BMX-010 is thought to treat a wide variety of inflammatory disorders. The main purpose of this study is to learn about the safety of the study drug. The primary purpose is to determine how much and how often BMX-010 can be safely given to patients with AD or PS. We ...

Phase

A phase 2 research study of a subcutaneous injection of investigational medication for adults ages 18 and older with moderate to severe atopic dermatitis, who have not received prior treatment with dupilumab. Note: Study participants will receive either the investigational medication or placebo. The trial comprises four periods: screening (up ...

Phase

The objective of this study is to investigate if the study medication is effective in reducing eczema symptoms for those with moderate to severe eczema. This is a 65-week study with up to 17 office visits.  

Phase